UBS Group
EHC icon

UBS Group’s Encompass Health EHC Stock Holding History

UBS Group’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,800
Closed -$1.57M – 10447
2025
Q2 		$1.57M Buy
+12,800
New +$1.46M ﹤0.01% 5050
2022
Q1 		– Sell
-73,409
Closed -$3.81M – 10397
2021
Q4 		$3.81M Buy
+73,409
New +$3.79M ﹤0.01% 3131
2020
Q1 		– Sell
-21,495
Closed -$1.19M – 8052
2019
Q4 		$1.19M Buy
+21,495
New +$1.17M ﹤0.01% 4043

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

UBS Group's EHC Position: Q1 2026 in Review

UBS Group increased its Encompass Health (EHC) stake by 35% in Q1 2026, buying an estimated $13.1M and bringing the position to 496,136 shares worth $48M. The position accounts for 0.01% of the portfolio, ranked #1687.

UBS Group first reported a position in EHC in Q4 2014 and has held it in 46 quarters since. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • UBS Group held 496,136 shares of Encompass Health worth $48M as of Q1 2026.
  • UBS Group bought 127,888 Encompass Health shares in Q1 2026, an estimated $13.1M.
  • Encompass Health made up 0.01% of UBS Group's portfolio in Q1 2026, its #1687 holding.
  • UBS Group first reported a position in Encompass Health in Q4 2014 and has held it in 46 quarters since.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.